| Literature DB >> 25695253 |
Stefania Marsili1, Sem Genini1, Raghavi Sudharsan1, Jeremy Gingrich1, Gustavo D Aguirre1, William A Beltran1.
Abstract
PURPOSE: To examine the occurrence of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) following acute light damage in the naturally-occurring canine model of RHO-adRP (T4R RHO dog).Entities:
Mesh:
Substances:
Year: 2015 PMID: 25695253 PMCID: PMC4335018 DOI: 10.1371/journal.pone.0115723
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of the experimental procedures performed in the dogs of this study.
| Animal ID | Genotype | Age (weeks) | Sex | Light treatment | PE interval (hrs) | Analysis | |
|---|---|---|---|---|---|---|---|
| shielded | exposed | ||||||
|
| |||||||
| EM335 | T4R/+ | 115 | M | RE | LE | 3 | H&E/TUNEL assay |
| EM339 | T4R/+ | 115 | F | RE | LE | 6 | H&E/TUNEL assay |
| EM340 | T4R/+ | 115 | F | RE | LE | 24 | H&E/TUNEL assay |
| EM232 | T4R/T4R | 17 | F | RE | LE | 0.25 | TEM |
| EM291 | T4R/+ | 20 | F | RE | LE | 0.25 | TEM |
| EM188 | T4R/T4R | 41 | F | RE | LE | 1 | TEM |
| E1051 | T4R/+ | 17 | F | RE | LE | 6 | TEM |
| EM276 | T4R/T4R | 12 | F | RE | LE | 6 | RNA (qRT-PCR)/(RT-PCR) |
| EM277 | T4R/T4R | 12 | F | RE | LE | 6 | RNA (qRT-PCR)/(RT-PCR) |
| EM278 | T4R/T4R | 12 | F | RE | LE | 6 | RNA (qRT-PCR)/(RT-PCR) |
| EM279 | T4R/T4R | 12 | F | RE | LE | 6 | Western Blot (UPR & HSR) |
| EM267 | T4R/+ | 12 | F | RE | LE | 6 | Western Blot (UPR & HSR) |
| EM160 | T4R/+ | 23 | F | RE | LE | 1 | Western Blot (Calpain study) |
| EM157 | T4R/+ | 23 | M | RE | LE | 3 | Western Blot (Calpain study) |
| EM156 | T4R/+ | 23 | M | RE | LE | 6 | Western Blot (Calpain study) |
|
| |||||||
| P1471 | +/+ | 21 | F | RE | LE | 0.25 | TEM |
| EM262 | +/+ | 16 | F | RE | LE | 6 | Western Blot (UPR & HSR) |
| M2367 | +/+ | 278 | F | RE | / | / | Western Blot (UPR & HSR) |
| M1841 | +/+ | 172 | F | RE | / | / | Western Blot (UPR & HSR) |
RE: right eye; LE: left eye; H&E: Hematoxylin & Eosin histology stain; TEM: Transmission Electron Microscopy; UPR: unfolded protein response; HSR: heat shock response; qRT-PCR: quantitative real time-PCR, RT-PCR: reverse transcription PCR.
LE*: Light exposure performed using a hand-held fundus camera and taking a series of sequential overlapping retinal photographs (see methods and [26–27]).
LE◇: Light exposure performed using a monocular Ganzfeld and delivering a constant bright white light (6500 K, corneal irradiance: 1mW/cm2) for 1 min (see methods).
List of forward (F), reverse (R), or TaqMan expression assay (Applied Biosystems) used for qRT-PCR.
| Gene | Gene description [NCBI Reference Sequence] | Sequence (5'-3') or expression assay (ABI) number |
|---|---|---|
|
| glyceraldehyde-3-phosphate dehydrogenase [NM_002046.3] | TaqMan gene expression assay: Hs02786624_g1 |
|
| MAP3K5 mitogen-activated protein kinase kinase kinase 5[XM_533420.5] | F: TCCCAGAGAGAGATAGCAGATAC R: CTCACTGAAAGAGCCCAGATAC |
|
| activating transcription factor 4 (tax-responsive enhancer element B67), transcript variant 2 [XM_854584] | F: CGAATGGCTGGCTTTGGA R: GTCCCGGAGAAGGCATCCT |
|
| heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa), transcript variant 5 ( | F: TGAAGTCACCTTTGAGATAGATGTGA R: TGTTGCCCGTACCTTTGTCTT |
|
| Caspase 3 [NM_001003042.1] | F: TCGAAGCGGACTTCTTGTATG R: ACTCAAGCTTGTGAGCGTATAG |
|
| Caspase 12 [NM_001077236.1] | F: GGCCGTCTGGGTGACTGAT R: ACTGCAAGGGCTGGTCACAT |
|
| DNA-damage-inducible transcript 3 (DDIT3) [XM_844109.2] | F: CCCCTTGGGCCACTACCTA R: TCGTTGGCACTGGAGAAGATG |
|
| DnaJ (Hsp40) homolog, subfamily A, member 1 [NM_001252143] | F: CTCTTGACAACCGAACCATCGT R: ACACACTTGATATCCCCATGCTT |
|
| DnaJ (Hsp40) homolog, subfamily B, member 1, transcript variant 2 [XM_847807] | F: CCCACCCGAAAGAAGCAA R: ATAGATCTCTTCAAGCGAGACCCTAAG |
|
| DnaJ (Hsp40) homolog, subfamily B, member 11[XM_535834.3] | F: GGAGAAGGTGAGCCTCATGTG R: ATTGGGTGCTTGACAACTTTGAT |
|
| ER degradation enhancer, mannosidase alpha-like 1[XM_533753.4] | F: GTCGGGAAGCCTGTAATGAA R: GGCATCTTCCACATCTCCTATC |
|
| ER degradation enhancer, mannosidase alpha-like 2[XM_859274.3] | F: CTTTGAGTACCTGGTGAAAGGA R: CAGTCATCGAAGCGAGTGTAA |
|
| ER degradation enhancer, mannosidase alpha-like 3[XM_537162.4] | F: GAGTAGGGAGGAGAGACAGAAG R: ATGAGTTCATCAGCTGGGTAAG |
|
| synovial apoptosis inhibitor 1, synoviolin (SYVN1) [XM_540867] | F: GGCTGTGTACATGCTCTACACAGA R: CGTGTGCACCTTGATCATGAT |
|
| heat shock protein 70 [NM_001003067.1] | F: GCGGAAAAGGACGAGTTTGAG R: CTGGTACAGTCCGGTGATGATG |
|
| heat shock protein 90kDa alpha (cytosolic), class A member 1, transcript variant 1 [XM_537557] | F: AGCTTGGGCTCGGTATCGA R: ACTCACCGCAGCACTACTATCGT |
|
| heat shock protein 90kDa alpha (cytosolic), class B member 1, transcript variant 1 [XM_532154] | F: AGATCACCTGGCAGTCAAGCA R: GATGAACAGCAATGCCCTGAAT |
|
| heat shock protein 90kDa beta (Grp94), member 1 [NM_001003327] | F: TGAAAGATAAAGCTCTCAAGGACAAGA R: AGCACACGGAGACTCTGTCAGA |
|
| valosin containing protein[XM_847533.3] | F: CAAACGAGAGGATGAGGAAGAG R: GCCTTAAAGAGAGCAGGATGT |
|
| X-box binding protein 1 [XM_849540.2] | F: ATGGATACCCTGGCTACTGAAGAG R: CACCGGCCTCACTCCATT |
|
| X-box binding protein 1Unspliced form | F: ACTGAAGAGGAGGCGGAGAC R: GCAGAGGTGCACGTAGTCTG |
|
| X-box binding protein 1Spliced form | F: GGGATGGATACCCTGGCTAC R: CACCTGCTGCGGACTCAG |
|
| X-box binding protein 1 [XM_849540.2] | F: TTACGAGAGAAAACTCATGGCC R: GGATCCAAGTTGAACAGAATGC |
Note: GAPDH was analyzed with TaqMan reagents, while all other genes with SYBR green.
The asterisk (*) indicates the set of primers used to detect total XBP1 (spliced and unspliced transcripts by RT-PCR.
List of primary antibodies successfully used for western blotting in the current study.
| Antigen / (species) | Host | Source, Catalog No. or Name | Working Dilution |
|---|---|---|---|
| BIP/GRP78 / (human) | Rabbit mc | C.S.T.: # 3177 | 1:500 |
| Calnexin / (human) | Rabbit pc | Abcam: # 13505 | 1:2000 |
| Cleaved Caspase-3 (Asp175) / (human) | Rabbit pc | C.S.T.:# 9661 | 1:1,000 |
| eIF2α / (human) | Rabbit pc | C.S.T.: # 9722 | 1:1000; 1:500 |
| Phospho-eIF2α (ser51) / (human) | Rabbit pc | C.S.T.: # 9721 | 1:1000; 1:500 |
| GRP94 / (human) | Rabbit pc | C.S.T.: # 2104 | 1:1000; 1:500 |
| HSP70 / (human) | Rabbit pc | C.S.T.: # 4872 | 1:500 |
| HSP70 (D69) / (human) | Rabbit pc | C.S.T.: # 4876 | 1:500 |
| HSP90 / (human) | Rabbit pc | C.S.T.: # 4875 | 1:1000 |
| XBP1 / (human) | Rabbit pc | A.S.B.: ARP38553_P050 | 1:1000 |
| Spectrin / (chicken) | Mouse mc | EMD Millipore: MAB1622 | 1:2000 |
| m-calpain (Calpain II) / (rat) | Rabbit pc | Chemicon: AB81013 | 1:5000 |
| β-actin / (chicken) | Mouse mc | EMD Millipore: MAB1501 | 1:20000 |
| β-actin / (human) | Mouse mc | Abcam:.# 8226 | 1:5000 |
| α-tubulin / (human) | Rabbit pc | C.S.T.: # 2144 | 1:1000 |
pc: polyclonal antibody; mc: monoclonal antibody; A.S.B.: Aviva Systems Biology, San Diego, CA; C.S.T.: Cell Signaling Technology, Charlottesville, VA; S.C.T.: Santa Cruz Biotechnology, Santa Cruz, California.
List of primary antibodies that were tested but failed to detect by western blotting the specific antigen in canine retina lysates when used overnight at the indicated dilution.
| Antigen / (species) | Host | Source, Catalog No. or Name | Working Dilution |
|---|---|---|---|
| Activating Transcription factor 4 (ATF4) / (human, dog) | Rabbit pc | A.S.B.: # ARP38067_T100 | 1:1000 |
| Activating Transcription factor 6 (ATF6) / (human) | Rabbit pc | S.C.B.: # sc-22799 | 1:500; 1:200 |
| Activating Transcription factor 6 (ATF6) / (human, dog) | Rabbit pc | A.S.B.: # ARP32293_P050 | 1:1000; 1:500 |
| Activating Transcription factor 6 (ATF6) / (human) | Rabbit pc | A.S.B.: # ARP31688_P050 | 1:750; 1:500 |
| ASK1 / (human) | Mouse mc | Novus Biologicals: #H00004217-M03 | 1:500 |
| p-ASK1 (Thr-485) / (mouse) | Rabbit pc | C.S.T.: #3765 | 1:1,000 |
| Caspase-12 / (mouse) | Rabbit pc | Abcam: # ab87348 | 1:50 |
| CHOP (GADD153/DDIT3) / (human) | Rabbit pc | Sigma: # G6916 | 1:250 |
| CHOP (GADD153/DDIT3) / (mouse) | Rabbit pc | S.C.B.:# sc-575 | 1:200 |
| CHOP (GADD153/DDIT3) / (human, pig) | Rabbit pc | A.S.B.:# ARP31591_P050 | 1:500 |
pc: polyclonal antibody; mc: monoclonal antibody; A.S.B.: Aviva Systems Biology, San Diego, CA; C.S.T.: Cell Signaling Technology, Charlottesville, VA; S.C.T.: Santa Cruz Biotechnology, Santa Cruz, California.
Fig 1Histological alterations and photoreceptor cell death in T4R RHO retinas following acute light exposure.
Representative photomicrographs of H&E stained retinal cryosections from RHOT4R/+ mutant dogs at 3, 6, and 24 hours following light exposure (LE) to a 1 min duration white light (corneal irradiance: 1mW/cm2). Sequential sections were used for TUNEL assay to detect the occurrence of cell death. Note that the RPE in the inferior retina is pigmented. Photomicrographs illustrate alterations seen in the tapetal /superior and non-tapetal/inferior central retina (approx. 3,000 μm from the ONH) which were first seen at 6 hours post LE and were most severe at 24 hours post LE with prominent disruption of the inner and outer segments, folding of the outer nuclear layer, and numerous features of TUNEL-positive cells. ONL: outer nuclear layer, IS; inner segments; OS; outer segments; RPE; retinal pigment epithelium; T: tapetum; scale bar = 20 μm.
Fig 2Ultrastructural alterations in rods following acute light exposure in T4R RHO canine retinas.
Transmission electron micrographs of photoreceptors from T4R RHO mutant and WT canine retinas at 15 min, 1 hour, and 6 hours after light exposure (LE) to a 1 min duration of white light (corneal irradiance: 1mW/cm2). Black arrowheads point to vesiculo-tubular structures located in the rod outer segments (ROS) and rod inner segments (RIS) of light exposed mutant retinas. Note that the CIS and COS remain normal even though there is extensive rod degeneration. CIS; cone inner segment; m: mitochondria.
Fig 3Luminal ER chaperones in T4R RHO and WT canine retinas 6 hours after light exposure.
(A) Differential expression of genes HSP90B1/GRP94, DNAJB11, EDEM1, EDEM2, and EDEM3 in the retinas of three RHO T4R/T4R mutant dogs following light exposure. Displayed are the mean fold change (FC) differences compared to the contralateral shielded retinas. Error bars represent the FC range (FC min to FC max). (B) Immunoblots showing the protein level of ER luminal chaperones GRP94 and Calnexin in light exposed (E) compared to shielded (S) retinas of mutant (RHO T4R/T4R, and RHO T4R/+), and wild-type RHO (+/+) dogs. A single retina from a wild-type dog kept under standard ambient kennel illumination (K) was included as a control of basal levels of GRP94, and calnexin proteins. There is no change in protein levels associated with light exposure.
Fig 4PERK-elF2α-ATF4 pathway in mutant T4R RHO and WT canine retinas 6 hours after light exposure.
(A) Immunoblots showing the protein levels of total and phosphorylated forms of eIF2α in light exposed (E) compared to shielded (S) retinas of mutant (RHO T4R/T4R, and RHO T4R/+), and WT (+/+) dogs. A single retina from a WT dog kept under standard ambient kennel illumination (K) was included as a control of basal levels of total and phosphorylated eIF2α. MDCK cells either treated with DMSO or Tunicamycin (Tun) were used as controls of P-eIF2α expression and antibody specificity. (B) Differential expression of gene ATF4 in the retinas of three RHO T4R/T4R mutant dogs following light exposure. Displayed is the mean fold change (FC) difference compared to the contralateral shielded retinas. Error bars represent the FC range (FC min to FC max).
Fig 5IRE1-XBP1 pathway in mutant T4R RHO and WT canine retinas 6 hours after light exposure.
(A) RT-PCR analysis of XBP1 splicing in light exposed (E) compared to shielded (S) T4R RHO and WT retinas. RT-PCR of canine XBP1 generated a 289 bp fragment, which represents the unspliced form of canine XBP1. The 263 bp fragment, which represents the spliced form of canine XBP1 was not observed except in the tunicamycin treated normal canine fibloblasts (NCF). A retina from a wild-type dog kept under standard ambient kennel illumination (K) was used as a control of basal XBP1 expression and splicing. (B) Differential expression of genes XBP1 and ASK1 in the retinas of three RHO T4R/T4R mutant dogs following light exposure. Three different sets of primers were used to specifically amplify the unspliced (u), spliced (s) and both (total) XBP1 transcripts. Displayed are the mean fold change (FC) difference compared to the contralateral shielded retinas. Error bars represent the FC range (FC min to FC max). (C) Immunoblots showing the protein levels of total and phosphorylated forms of XBP1 in light exposed (E) compared to shielded (S) retinas of mutant (RHO T4R/T4R, and RHO T4R/+), and WT (+/+) dogs. A single retina from a wild-type dog kept under standard ambient kennel illumination (K) was included as a control of basal levels of XBP1.
Fig 6Downstream targets of the unfolded protein response (BIP and CHOP) in mutant T4R RHO and WT canine retinas 6 hours after light exposure.
(A) Differential expression of genes BIP/GRP78 and CHOP in the retinas of three RHO T4R/T4R mutant dogs following light exposure. Displayed are the mean fold change (FC) differences compared to the contralateral shielded retinas. Error bars represent the FC range (FC min to FC max). (B) immunoblots showing the protein levels of BIP/GRP78 in light exposed (E) compared to shielded (S) retinas of mutant (RHO T4R/T4R, and RHO T4R/+), and WT (+/+) dogs. A single retina from a wild-type dog kept under standard ambient kennel illumination (K) was included as a control of basal levels of BIP/GRP78. MDCK cells either treated with DMSO or Tunicamycin (Tun) were used as controls of BIP/GRP78 expression and antibody specificity; tunicamycin results in increased levels of BIP/GRP78.
Fig 7Cytosolic markers of ER associated stress and ER associated degradation (ERAD) in mutant T4R RHO and WT retinas 6 hours after light exposure.
(A) Differential expression of genes VCP, HRD1, DNAJA1, DNAJB1, HSP70, HSP90AA1, HSP90AB1, and CASP12 in the retinas of three RHO T4R/T4R mutant dogs following light exposure. Displayed are the mean fold change (FC) differences compared to the contralateral shielded retinas; error bars represent the FC range (FC min to FC max) (*: p < 0.05). (B) immunoblots showing the protein levels of HSP90 and HSP70 in light exposed (E) compared to shielded (S) retinas of mutant (RHO T4R/T4R, and RHO T4R/+), and WT (+/+) dogs. A single retina from a wild-type dog kept under standard ambient kennel illumination (K) was included as a control of basal levels of HSP90 and HSP70. There are no changes in HSP90 and HSP70 protein levels associated with light exposure. Note: the HSP90 antibody used recognizes the products of both the HSP90AA1 and HSP90AB1 genes.
Fig 8Effect of light exposure on calpain activation in mutant T4R RHO retinas.
(A) Immunoblots showing the protein levels of full length and calpain-produced 150 kDa alpha II Spectrin signature breakdown product (SBDP), as well as that of m-calpain in shielded and exposed retinas of RHO T4R/+ dogs at 1, 3, and 6 hours after light exposure from photographs with a Kowa RC2 fundus camera. (B) canine MDCK cells treated with staurosporine were used as a positive control for detection of both the calpain-cleaved (150 kDa) and caspase-3-cleaved (120 kDa) SBDPs with the antibody directed against α-II-spectrin. (C) Immunoblots showing the absence of detection of cleaved caspase-3 in shielded and exposed retinas of RHO T4R/+ dogs at 1, 3, and 6 hours after light exposure. Staurosporine-treated MDCK cells were used as positive control. (D) Differential expression of gene CASP3 in the retinas of three RHO T4R/T4R mutant dogs 6 hours following light exposure. Displayed are the mean fold change (FC) differences compared to the contralateral shielded retinas; error bars represent the FC range (FC min to FC max).
Fig 9Schematic representation of the signaling pathways activated during ER stress.
ER stress-related markers investigated in this study are highlighted in red (RNA), blue (protein) and yellow (both RNA and protein). (modified from [35]).